69 related articles for article (PubMed ID: 1981513)
1. Pharmacokinetics of flobufen and its main active metabolite in the rat.
Lapka R; Smolík S; Rejholec V
Drug Metab Dispos; 1990; 18(6):1060-4. PubMed ID: 1981513
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective pharmacokinetics and metabolism of flobufen in guinea pigs.
Trejtnar F; Král R; Pávek P; Wsól V
Chirality; 2003 Oct; 15(8):724-9. PubMed ID: 12923810
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective pharmacokinetics of flobufen in rats.
Trejtnar F; Wsol V; Szotakova B; Skalova L; Pavek P; Kuchar M
Chirality; 1999; 11(10):781-6. PubMed ID: 10561708
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and pharmacokinetics of 1-(2'-trimethylacetoxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP117) in the rat.
Choudhury R; Epemolu RO; Rai BL; Hider RC; Singh S
Drug Metab Dispos; 1997 Mar; 25(3):332-9. PubMed ID: 9172951
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in rats.
Epemolu OR; Singh S; Hider RC; Damani LA
Drug Metab Dispos; 1992; 20(5):736-41. PubMed ID: 1358580
[TBL] [Abstract][Full Text] [Related]
6. [Disposition of [3H]flobufen and its active metabolite in rats].
Lapka R; Brejcha A; Smolík S; Franc Z
Cesk Farm; 1990 Dec; 39(10):443-7. PubMed ID: 2090343
[TBL] [Abstract][Full Text] [Related]
7. Disposition of exaprolol, a new beta-blocker, in rats.
Trnovec T; Zemánek M; Faberová V; Bezek S; Durisová M; Ujházy E; Tomcíková O
Drug Metab Dispos; 1982; 10(5):547-50. PubMed ID: 6128208
[TBL] [Abstract][Full Text] [Related]
8. Stereospecificity of flobufen metabolism in guinea pigs in vitro and in vivo: phase I of biotransformation.
Kral R; Skalova L; Szotakova B; Babu YN; Wsol V
Chirality; 2004 Jan; 16(1):1-9. PubMed ID: 14628293
[TBL] [Abstract][Full Text] [Related]
9. Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds.
Fura A; Vyas V; Humphreys W; Chimalokonda A; Rodrigues D
Biopharm Drug Dispos; 2008 Nov; 29(8):455-68. PubMed ID: 18989850
[TBL] [Abstract][Full Text] [Related]
10. Presystemic and systemic intestinal metabolism of fenoterol in the conscious rat.
Koster AS; Hofman GA; Frankhuijzen-Sierevogel AC; Noordhoek J
Drug Metab Dispos; 1985; 13(4):464-70. PubMed ID: 2863112
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of (-)-carbovir in rats. Evidence for nonlinear elimination.
Brouwer KR; St Claire RL; Lagarde J; Patanella JE; Walsh JS; Miwa GT
Drug Metab Dispos; 1990; 18(6):1078-83. PubMed ID: 1981516
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of the anti-AIDS drug 2',3'-dideoxyinosine in the rat.
Ray GF; Mason WD; Badr MZ
Drug Metab Dispos; 1990; 18(5):654-8. PubMed ID: 1981715
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of [3H]1-[1-(2-thienyl)cyclohexyl]piperidine (TCP) in Sprague-Dawley rats.
Zorbas M; Owens SM; Plunkett LM; Bui H
Drug Metab Dispos; 1989; 17(6):641-5. PubMed ID: 2575500
[TBL] [Abstract][Full Text] [Related]
14. A spectrophotometric method for N-nicotinoyl-tryptamine (tryptamide) assay in the blood serum of rats.
Danek L; Rurak A; Melzacka M
Pol J Pharmacol Pharm; 1987; 39(6):773-7. PubMed ID: 2973003
[TBL] [Abstract][Full Text] [Related]
15. Toxicokinetics and bioavailability of oral and intravenous 1,1-dichloroethylene.
Putcha L; Bruckner JV; D'Souza R; Desai F; Feldman S
Fundam Appl Toxicol; 1986 Feb; 6(2):240-50. PubMed ID: 3699314
[TBL] [Abstract][Full Text] [Related]
16. Stereospecificity and stereoselectivity of flobufen metabolic profile in male rats in vitro and in vivo: phase I of biotransformation.
Wsól V; Král R; Skálová L; Szotáková B; Trejtnar F; Flieger M
Chirality; 2001; 13(10):754-9. PubMed ID: 11746815
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent pharmacokinetics of ibuprofen in the rat.
Shah A; Jung D
Drug Metab Dispos; 1987; 15(2):151-4. PubMed ID: 2882970
[TBL] [Abstract][Full Text] [Related]
18. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
19. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
